Human Coronavirus 229E Infection Alters Histone Proteoforms

View at publisher
Authors: Ashley N. Ives, Stephanie M. Thibert, Madelyn R. Berger, Matthew J. Gaffrey, Hugh D. Mitchell, Sarai M. Williams, Mowei Zhou, Katrina M. Waters, Amy C. Sims, Tong Zhang
Cited by: 1
References: 72

Abstract

Viruses rely on host machinery to replicate, and growing evidence demonstrates that they utilize host epigenetic regulation, including histone modification, to modulate host gene expression for their benefit. Herein, we employed top-down proteomics to quantify histone proteoforms in lung fibroblast (MRC-5) cells following human coronavirus 229E (HCoV-229E) infection and compared them to mock-infected controls. A total of 572 proteoforms were identified, including 461 histone proteoforms that were assigned to histone 2A (H2A), H2B, H3, or H4. 200 histone proteoforms were quantifiable. Differential abundance analysis revealed several changes in both reversible post-translational modifications (e.g., phosphorylation, acetylation) and the truncation states of core histones. Notably, we found a decreased abundance of truncated histones in HCoV-229E-infected samples, specifically C-terminally truncated histone H2A and N-terminally truncated histone H3. These findings underscore the power of top-down proteomics to resolve unique truncation states of proteoforms and support the hypothesis that viruses alter the histone length to influence host gene expression.

Fields of Study & Subjects

Genomics and Chromatin Dynamics Virus-based gene therapy research Histone Deacetylase Inhibitors Research

Publication details

Journal / source
Journal of Proteome Research
Publisher
American Chemical Society (ACS)
Volume
25
Issue
6
Pages
2698–2708
Publication date
28 April 2026
Language
EN